Fast and Accurate Antibody Sequence Design via Structure Retrieval
Xingyi Zhang, Kun Xie, Ningqiao Huang, Wei Liu, Peilin Zhao, Sibo Wang, Kangfei Zhao, Biaobin Jiang · 2025
Read Fast and Accurate Antibody Sequence Design via Structure Retrieval by Xingyi Zhang, Kun Xie, Ningqiao Huang, Wei Liu, Peilin Zhao, Sibo Wang, Kangfei Zhao, Biaobin Jiang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2502-19395.txt.
Introduction
Xingyi Zhang and co-authors design antibody sequences by retrieving like structures, in a framework called Igseek. Standard protein design builds a scaffold with a diffusion model, then infers a sequence from it. For the highly variable loops of antibodies, that inference often yields sequences that do not work.
Igseek instead embeds a loop backbone with a multi-channel equivariant graph neural network, then searches a database of natural antibodies for near matches. Aligned sequences from those matches, plus conserved motifs, guide the final sequence. Tests showed fast retrieval and better sequence recovery than leading methods, for both antibodies and T-cell receptors. The authors offer retrieval as a fresh route for therapeutic protein design.
Catalog record
| CREATOR | Xingyi Zhang, Kun Xie, Ningqiao Huang, Wei Liu, Peilin Zhao, Sibo Wang, Kangfei Zhao, Biaobin Jiang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2502-19395
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Fast and Accurate Antibody Sequence Design via Structure Retrieval Xingyi Zhang, Kun Xie, Ningqiao Huang, Wei Liu, Peilin Zhao, Sibo Wang, Kangfei Zhao, Biaobin Jiang Abstract Recent advancements in protein design have leveraged diffusion models to generate structural scaffolds, followed by a process known as protein inverse folding, which involves sequence inference on these scaffolds. However, these methodologies face significant challenges when applied to hyper-variable structures such as antibody Complementarity-Determining Regions (CDRs), where sequence inference frequently results in non-functional sequences due to hallucinations. Distinguished from prevailing protein inverse folding approaches, this paper introduces IgSeek, a novel structure-retrieval framework that infers CDR sequences by retrieving similar structures from a natural antibody database. Specifically, IgSeek employs a simple yet effective multi-channel equivariant graph neural network to generate high-quality geometric representations of CDR backbone structures. Subsequently, it aligns sequences of structurally similar CDRs and utilizes structurally conserved sequence motifs to enhance inference accuracy. Our experiments demonstrate that IgSeek not only proves to be highly efficient in structural retrieval but also outperforms state-of-the-art approaches in sequence recovery for both antibodies and T-Cell Receptors, offering a new retrieval-based perspective for therapeutic protein design. 1 Main Antibodies, known for their high specificity and affinity, have emerged as pivotal therapeutic agents in the treatment of complex diseases, including cancer Adams & Weiner (2005) , autoimmune disorders Feldmann & Maini (2003) , and infectious diseases Abraham (2020) . In 2023, the global best-selling drug was Keytruda, a cancer treatment antibody, with sales reaching \$25 billion, surpassing Humira, another antibody used for treating rheumatoid arthritis, which had dominated the market for the past decade ( Dunleavy, 2024 ) . Traditionally, the discovery of antibodies has predominantly relied on immunizing animals with antigens Van Wauwe et al. (1980) or employing various display techniques such as phage MacCallum et al. (1996) and yeast displays Chao et al. (2006) . However, these approaches face significant challenges when dealing with structurally intricate proteins, which are difficult to express in a soluble and functional form. Additionally, even when numerous candidate antibodies are generated through these techniques, they may not necessarily bind to the desired domain or exhibit therapeutic efficacy. To overcome these limitations, deep learning models have been introduced to design synthetic antibodies by learning from natural antibody-antigen complexes Luo et al. (2022) ; Jin et al. (2022) ; Kong et al. (2023a) ; Kong et al. (2023b) ; Bennett et al. (2024) . Despite significant strides in protein design Dauparas et al. (2022) ; Hsu et al. (2022) ; Notin et al. (2024) , antibodies present a distinct challenge for deep learning due to the high flexibility of their binding regions, known as complementarity-determining regions (CDRs). Inspired by RFdiffusion’s Watson et al. (2023) remarkable achievements in monomeric protein and binder design, Bennett et al. Bennett et al. (2024) advanced the field by fine-tuning the RFdiffusion model with antibody-antigen complex structural data to facilitate epitope-targeted antibody design. Their approach aligns well with established pharmaceutical practices by generating different CDRs on the same framework for different antigen targets, thereby enhancing developability and reducing downstream optimization requirements. While structural and functional analyses validated the its capability to generate antibodies that bind to predetermined epitopes, the approach was constrained by notably low success rates. One reason for the low success rate of this AI-based antibody design pipeline is the occurrence of hallucinations, especially during the process of protein inverse folding, which predicts the CDR sequence based on the backbone structure Dauparas et al. (2022) ; Hsu et al. (2022) ; Gruver et al. (2023) ; Gao et al. (2023b) . To be specific, given an antigen epitope and an antibody backbone, the amino acid sequences inferred through methods like ProteinMPNN Dauparas et al. (2022) and ESM-IF1 Hsu et al. (2022) may not fold into the desired structures in real biological systems. More critically, there are currently no effective computational methods to reduce these hallucinations, aside from conducting time-consuming, labor-intensive, and expensive wet-lab experiments for validation. Typically, using independent structure prediction models to fold and verify the inferred sequences cannot effectively eliminate non-functional sequences caused by hallucinations. That is because even state-of-the-art models exhibit structural deviations of 1 to 3 Å and have low confidence in predicting the structures of antibody CDRs. Figure 1: The Framework IgSeek: (a) Pre-train an MEGNN encoder by a self-supervised learning task. (b) Construct a CDR vector database. (c) Sequence generation by K-NN search. To deal with the challenge of hallucinations arising from previous models, we propose an antibody CDR sequence design framework from a novel perspective of similar structure retrieval, named as IgSeek (Ig for Immunoglobulin, a.k.a. antibody). Our framework is enlightened by a noteworthy empirical discovery made 25 years ago, which revealed that antibodies exhibit a limited set of canonical structures within 5 out of 6 CDRs despite the vast diversity in sequences, and that certain CDR conformations are scaffolded by a few highly conserved residues Chothia et al. (1989) . Further inspired by retrieval-augmented prediction for hallucination reduction in protein structure prediction Jumper et al. (2021) , and natural language generation Gao et al. (2023a) , IgSeek leverages neural retrieval in a database of natural antibodies to retrieve structurally similar sequence templates of CDR, and ensembles the queried templates for sequence prediction. Extensive experimental validation demonstrates that our structure-guided retrieval approach effectively improves the accuracy of CDR sequence prediction, notably outperforming state-of-the-art sequence design methods. 2 Results 2.1 IgSeek Approach The gist of IgSeek for structure-to-sequence generation is isomorphic structure retrieval, which allows for the exploration of a large and diverse antibody CDR structure database. Fig. 1 illustrates the framework of IgSeek. Given an antibody CDR database where both structures and sequences are available, IgSeek first constructs a CDR vector database, where vector embeddings index the structural proximity of the CDRs. In this offline stage, we pre-train a Multi-channel Equivariant Graph Neural Network (MEGNN) to encode the structure of CDR loops into fixed-length vectors within the CDR database. Specifically, MEGNN aligns the spatial structure distance between pairs of CDRs with equal lengths and similar conformations. Subsequently, for a CDR structure G whose sequence is to be predicted, we first deploy the pre-trained MEGNN to generate an embedding \bm{h}_{G} for G . \bm{h}_{G} then serves as the search key to query the K -nearest neighbors ( K -NN) structurally similar CDR loops in the vector database. Finally, the K -NN results, associated with their corresponding residue sequences, are collected to predict the sequence of G by ensemble and Bernoulli sampling.A detailed description of our methodology can be found in Appendix C . Datasets. We evaluate our IgSeek and other baselines using both solved and predicted antibody structures. The training set consists of CDR pairs sampled from 11,023 solved CDR loops in the Structural Antibody Database (SAbDab) ( Dunbar et al., 2013 ; Schneider et al., 2021 ) . To construct the CDR vector database, we utilize 24,479 solved CDR loops from SAbDab before January 1, 2024 (SAbDab-before-2024). In addition, 4,449 solved CDR loops released between January 3, 2024 and May 29, 2024 from SAbDab (SAbDab-2024) serve as the test set to evaluate the performance of IgSeek and its competitors. In addition to the solved antibody structures from SAbDab, we also conduct